Gallery of new files
Jump to navigation
Jump to search
This special page shows the last uploaded files.
-
Effects of hepatic impairment and renal impairment on daridorexant PK.png Edzelco
21:07, 31 January 2024
1,230 × 788; 248 KB
-
Effect of daridorexant on the PK of other compounds.png Edzelco
21:07, 31 January 2024
1,250 × 1,086; 543 KB
-
Effect of co-administered compounds on the PK of daridorexant.png Edzelco
21:06, 31 January 2024
1,274 × 1,096; 454 KB
-
Allergic bronchopulmonary aspergillosis.gif Laith Adnan Allaham
13:10, 7 June 2023
407 × 440; 155 KB
-
Table 4 Clinical Data Trial 1 and 2.png Tejasvi Aryaputra
16:09, 20 January 2023
1,328 × 1,226; 254 KB
-
Ibrexafungerp Table 1 Adverse Reactions (Trials 1 and 2).png Tejasvi Aryaputra
16:09, 20 January 2023
1,296 × 516; 95 KB
-
Aducanumab-avwa Table 8 Study 2 Biomarkers.png Tejasvi Aryaputra
21:59, 10 January 2023
1,006 × 990; 196 KB
-
Aducanumab-avwa Table 7 Clinical Results Study 1.png Tejasvi Aryaputra
21:59, 10 January 2023
1,000 × 1,318; 214 KB
-
Aducanumab-avwa Table 6 Study 1 Biomarkers.png Tejasvi Aryaputra
21:59, 10 January 2023
1,350 × 1,318; 231 KB
-
Aducanumab-avwa Table 5 Adverse Reactions.png Tejasvi Aryaputra
21:59, 10 January 2023
1,314 × 1,256; 214 KB
-
Aducanumab-avwa Table 4 ARIA Classification.png Tejasvi Aryaputra
21:59, 10 January 2023
1,326 × 926; 176 KB
-
Aducanumab-avwa Table 3 Dosing Modifciations.png Tejasvi Aryaputra
21:58, 10 January 2023
1,308 × 748; 147 KB
-
Aducanumab-avwa Table 2 Dosing Monitoring.png Tejasvi Aryaputra
21:58, 10 January 2023
1,330 × 718; 136 KB
-
Aducanumab-avwa Figure 4 Clinical Studies.png Tejasvi Aryaputra
21:57, 10 January 2023
1,014 × 944; 305 KB
-
Aducanumab-avwa Figure 3 Clinical Studies.png Tejasvi Aryaputra
21:57, 10 January 2023
1,012 × 990; 219 KB
-
Aducanumab-avwa Figure 2 Clinical Studies.png Tejasvi Aryaputra
21:57, 10 January 2023
1,350 × 1,206; 268 KB
-
Aducanumab-avwa Figure 1 Clinical Studies.png Tejasvi Aryaputra
21:57, 10 January 2023
1,352 × 1,318; 350 KB
-
Aducanumab-avwa Drug Label (3 mL).png Tejasvi Aryaputra
21:56, 10 January 2023
1,362 × 1,100; 583 KB
-
Aducanumab-avwa Drug Label (1.7 mL).png Tejasvi Aryaputra
21:56, 10 January 2023
1,352 × 1,102; 578 KB
-
Rylaze Table 2 Dosage Modifications.png Tejasvi Aryaputra
13:46, 3 January 2023
1,006 × 1,498; 348 KB
-
Upper GI bleeding. Adapted from ACG Clinical Guideline- Upper Gastrointestinal and Ulcer Bleeding.png Jair Basantes de la Calle
13:54, 29 December 2022
1,920 × 1,080; 201 KB
-
Stage A and Stage B recommendations for HF. Adapted from 2022 AHA-ACC-HFSA Guideline for the Management of Heart Failure.png Jair Basantes de la Calle
21:21, 8 December 2022
1,920 × 1,080; 144 KB
-
Recommendation for blood pressure management. Adapted from the 2019 ACC-AHA Guideline on the Primary Prevention of Cardiovascular Disease. .png Jair Basantes de la Calle
19:24, 8 December 2022
1,920 × 1,080; 91 KB
-
Primary Prevention of ASCVD per age group.png Jair Basantes de la Calle
18:28, 8 December 2022
1,920 × 1,080; 318 KB
-
Diagnostic Algorithm for HF and EF-Based Classification.png Jair Basantes de la Calle
12:57, 28 November 2022
1,678 × 1,080; 171 KB
-
Finerenone Table 4 Clinical Studies.png Tejasvi Aryaputra
00:16, 6 September 2022
608 × 1,450; 175 KB
-
Finerenone Table 3 Adverse Reactions.png Tejasvi Aryaputra
00:15, 6 September 2022
1,004 × 656; 85 KB
-
Finerenone Table 2 Dosage Adjustments.png Tejasvi Aryaputra
00:15, 6 September 2022
1,142 × 898; 147 KB
-
Finerenone Figure 2 Clinical Studies.png Tejasvi Aryaputra
00:15, 6 September 2022
1,290 × 1,080; 519 KB
-
Finerenone Figure 1 Clincal Studies.png Tejasvi Aryaputra
00:15, 6 September 2022
1,326 × 1,158; 550 KB
-
Fexinidazole Table 5 Pharmocokinetics.png Tejasvi Aryaputra
02:11, 5 September 2022
640 × 1,514; 262 KB
-
Fexinidazole Table 4 Drug Interactions Pt.4.png Tejasvi Aryaputra
02:10, 5 September 2022
622 × 658; 133 KB
-
Fexinidazole Table 3 Drug Interactions Pt.1.png Tejasvi Aryaputra
02:10, 5 September 2022
612 × 1,028; 209 KB
-
Fexinidazole Table 2 Adverse Reactions Pt.2.png Tejasvi Aryaputra
02:10, 5 September 2022
610 × 546; 78 KB
-
Fexinidazole Table 2 Adverse Reactions.png Tejasvi Aryaputra
02:10, 5 September 2022
622 × 1,308; 188 KB
-
Belumosudil Table 2 Adverse Reactions.png Tejasvi Aryaputra
01:34, 30 August 2022
586 × 1,246; 135 KB
-
Belumosudil Table 2 Adverse Reactions Pt. 2.png Tejasvi Aryaputra
01:32, 30 August 2022
540 × 676; 136 KB
-
Odevixibat Table 3 Adverse Reactions.png Tejasvi Aryaputra
00:38, 25 August 2022
1,270 × 1,274; 218 KB
-
Odevixibat Package Label (1200 mcg).png Tejasvi Aryaputra
00:38, 25 August 2022
1,344 × 1,320; 470 KB
-
Odevixibat Package Label (600 mcg).png Tejasvi Aryaputra
00:38, 25 August 2022
1,348 × 1,448; 509 KB
-
Odevixibat Package Label (400 mcg).png Tejasvi Aryaputra
00:38, 25 August 2022
1,340 × 1,320; 471 KB
-
Odevixibat Package Label (200 mcg).png Tejasvi Aryaputra
00:38, 25 August 2022
1,344 × 1,446; 486 KB
-
•Prodrome weakness, malaise, myalgias, abdominal pain.png Hassan M
04:22, 7 August 2022
1,024 × 768; 106 KB
-
Anifrolumab-fnia Table 1 Adverse Reactions.png Tejasvi Aryaputra
18:22, 5 August 2022
1,312 × 1,370; 197 KB
-
Small-cell-lung-cancer-right-upper-lobe-collapse.jpg Hassan M
18:56, 31 July 2022
1,600 × 1,600; 245 KB
-
Avalglucosidase alfa-ngpt Table 5 Walking.png Tejasvi Aryaputra
18:51, 25 July 2022
1,216 × 970; 193 KB
-
Avalglucosidase alfa-ngpt Table 4 FVC.png Tejasvi Aryaputra
18:51, 25 July 2022
1,202 × 1,024; 208 KB
-
Avalglucosidase alfa-ngpt Table 3 Antibodies.png Tejasvi Aryaputra
18:50, 25 July 2022
612 × 856; 141 KB
-
Avalglucosidase alfa-ngpt Table 2 Adverse Reactions.png Tejasvi Aryaputra
18:50, 25 July 2022
1,204 × 1,162; 183 KB
-
Avalglucosidase alfa-ngpt Table 1 Infusion Rate.png Tejasvi Aryaputra
18:50, 25 July 2022
1,240 × 902; 134 KB
-
Avalglucosidase alfa-ngpt Packaging Label 2.png Tejasvi Aryaputra
18:50, 25 July 2022
646 × 156; 25 KB
-
Avalglucosidase alfa-ngpt Packaging Label.png Tejasvi Aryaputra
18:50, 25 July 2022
656 × 1,484; 230 KB
-
Avalglucosidase alfa-ngpt Figure 2 Walking.png Tejasvi Aryaputra
18:50, 25 July 2022
1,274 × 816; 238 KB
-
Avalglucosidase alfa-ngpt Figure 1 FVC.png Tejasvi Aryaputra
18:49, 25 July 2022
1,288 × 842; 241 KB
-
Avalglucosidase alfa-ngpt Drug Packaging.png Tejasvi Aryaputra
18:49, 25 July 2022
1,334 × 1,410; 713 KB
-
Belzutifan Table 3 Lab Abnormalities.png Tejasvi Aryaputra
18:55, 21 July 2022
1,192 × 1,210; 163 KB
-
Giemsa stain of bone marrow biopsy showing sheets of plasma cells..jpg Ariwoola Azeezat Oyetola
12:03, 21 July 2022
960 × 720; 191 KB
-
Difelikefalin Table 2 Adverse Reactions.png Tejasvi Aryaputra
20:14, 12 July 2022
1,328 × 1,196; 189 KB
-
Lonapegsomatropin-tcgd Table 6 Catridges.png Tejasvi Aryaputra
12:36, 5 July 2022
1,126 × 818; 92 KB
-
Lonapegsomatropin-tcgd Table 5 Height SDS.png Tejasvi Aryaputra
12:36, 5 July 2022
1,208 × 750; 128 KB
-
Lonapegsomatropin-tcgd Table 4 High Velocity.png Tejasvi Aryaputra
12:36, 5 July 2022
1,192 × 834; 163 KB
-
Lonapegsomatropin-tcgd Table 3 Drug Interactions.png Tejasvi Aryaputra
12:36, 5 July 2022
614 × 1,262; 255 KB
-
Lonapegsomatropin-tcgd Table 2 Adverse Reactions.png Tejasvi Aryaputra
12:35, 5 July 2022
1,272 × 1,132; 207 KB